[Intravenous immunoglobulins: therapeutic indications]

Area of Science:

• Immunology
• Hematology
• Neurology
• Pharmacology

Background:

• Intravenous immunoglobulins (IVIg) are derived from pooled human IgG from healthy donors.
• IVIg serves critical roles in both immune reconstitution and immunomodulation.

Purpose of the Study:

• To review the therapeutic applications of IVIg in immune deficiencies and autoimmune conditions.
• To discuss the complex and incompletely understood mechanisms of action of IVIg.
• To assess the safety profile and potential risks associated with IVIg therapy.

Main Methods:

• Literature review of IVIg applications and mechanisms.
• Analysis of clinical data regarding efficacy and adverse events.
• Synthesis of current understanding of IVIg's immunomodulatory pathways.

Main Results:

• IVIg is effective at low doses for primary/secondary immune deficiencies.
• High-dose IVIg demonstrates immunomodulatory effects in autoimmune and inflammatory diseases, particularly hematologic and neurologic conditions.
• Adverse effects are rare, and IVIg is generally well-tolerated.

Conclusions:

• IVIg is a versatile therapeutic agent with established roles in treating immune deficiencies and autoimmune disorders.
• The precise mechanisms underlying IVIg's immunomodulatory effects are complex and warrant further investigation.
• The risk of infectious agent transmission via IVIg is considered theoretical, with a favorable safety profile.